Russian vaccine

Published August 14, 2020

AS countries race to produce the first coronavirus vaccine, Russia’s claims that it has approved such a vaccine have been met with serious scepticism — and for good reason. Russia announced this week that the Sputnik V coronavirus vaccine has been given the green signal for extensive use and that the country was forging ahead with mass manufacturing and immunisation plans to kick off vaccination as early as October. President Vladimir Putin said the locally developed vaccine was given regulatory approval after less than two months of testing on humans, but that it had purportedly passed all the required checks. To silence naysayers, he added that his daughter had already been administered a dose. Worryingly, the head of the country’s sovereign wealth fund said there are international agreements to produce 500m doses and requests for 1bn doses from 20 countries. The announcement has sparked legitimate fears among experts, who said the Russian vaccine has bypassed ‘phase 3’ — a crucial trial stage which mass-tests an under-research vaccine on thousands of people to observe its efficacy. Professors and medical experts from reputable institutions have expressed concern over several aspects of this vaccine, and called into question the process through which it was approved. Some fear it is difficult to know how safe or effective it will be given that the work that went into its development was not transparent. The WHO has said vaccines must go through all stages of testing before being rolled out. Multiple experts have said vaccines that have not been properly tested can be detrimental in many ways, negatively impacting health or creating a false sense of security. What is more dangerous is that they can undermine trust in all vaccines.

While the world is understandably desperate for immunisation against Covid-19 due to the colossal toll the infection has taken on all aspects of life, jumping the gun when it comes to health matters can have dangerous consequences. Countries must proceed ethically and with caution before considering the mainstreaming of such a vaccine.

Published in Dawn, August 14th, 2020

Opinion

Editorial

Judiciary’s SOS
Updated 28 Mar, 2024

Judiciary’s SOS

The ball is now in CJP Isa’s court, and he will feel pressure to take action.
Data protection
28 Mar, 2024

Data protection

WHAT do we want? Data protection laws. When do we want them? Immediately. Without delay, if we are to prevent ...
Selling humans
28 Mar, 2024

Selling humans

HUMAN traders feed off economic distress; they peddle promises of a better life to the impoverished who, mired in...
New terror wave
Updated 27 Mar, 2024

New terror wave

The time has come for decisive government action against militancy.
Development costs
27 Mar, 2024

Development costs

A HEFTY escalation of 30pc in the cost of ongoing federal development schemes is one of the many decisions where the...
Aitchison controversy
Updated 27 Mar, 2024

Aitchison controversy

It is hoped that higher authorities realise that politics and nepotism have no place in schools.